Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more ...

Rx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it ...

Residents of Timișoara, in western Romania, can undergo free spirometry tests in a special tram as part of the ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

For patients with severely compromised lung function, an important treatment is supplemental oxygen. Flawed Medicare payment ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

A Facebook video that cobbles together unrelated footage of two celebrities to promote a purported cure for lung diseases isn’t authentic, despite the post’s claim that chronic obstructive pulmonary ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...

More than 20 respiratory conditions could receive extra financial support from PIP to help with daily living costs ...

PORTLAND, OR, UNITED STATES, December 9, 2024 /EINPresswire / -- The global pulmonary drug delivery systems market is experiencing significant growth, driven by various factors including the rising ...